Transcript PHF19-207 as a Potential Biomarker for Colon Cancer Diagnosis and Screening
Open Access
- 26 May 2025
- journal article
- Published by MDPI AG in Biomolecules
- Vol. 15 (6)
Abstract
A recent comprehensive pan-cancer study indicated the high translational potential of the transcript PHF19-207 as a biomarker for colon cancer. This study aimed to analyze the expression of PHF19-207 in colon tissue samples from two different settings to evaluate its clinical utility for diagnosis and screening. Surgical samples of colon tumor and non-tumor tissue were analyzed to determine the diagnostic value of PHF19-207 and its potential correlation with tumor characteristics. Additionally, biopsied samples from individuals undergoing national colorectal cancer screening were examined to assess the potential use of PHF19-207 in early detection. PHF19-207 expression levels were measured in all samples using Real-Time Polymerase Chain Reaction. A statistically significant difference was observed between tumor and non-tumor tissue (p = 0.002) and between tumor tissue and healthy mucosa samples (p < 0.001). Furthermore, polyp samples exhibited significantly higher PHF19-207 expression compared to healthy mucosa (p = 0.035). Receiver operating characteristic (ROC) analysis indicated that PHF19-207 can effectively differentiate malignant from healthy tissue, with an AUC value of 0.9044. Considering the increasing incidence of colorectal cancer in younger populations and the need for improved early detection, PHF19-207 expression could be explored as the basis for a relatively simple and efficient test, enabling a more comprehensive and affordable screening strategy.Keywords
Funding Information
- Science Fund of the Republic of Serbia (6052315, 451-03-136/2025-03/200042, 451-03-137/2025-03/200110)
- Ministry of Science, Technological Development and Innovation of the Republic of Serbia (6052315, 451-03-136/2025-03/200042, 451-03-137/2025-03/200110)
This publication has 32 references indexed in Scilit:
- Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targetsSignal Transduction and Targeted Therapy, 2024
- Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessmentJournal of Pathology Informatics, 2023
- Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo‐related genes in hepatocellular carcinomaCancer Medicine, 2021
- Non-coding RNAs and potential therapeutic targeting in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative PromotersCell, 2019
- Stromal contribution to the colorectal cancer transcriptomeNature Genetics, 2015
- Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010JAMA Surgery, 2015
- Clinical Usefulness of Serum CYFRA 21–1 in Patients with Colorectal CancerNuclear Medicine and Molecular Imaging, 2013
- AJCC Cancer Staging Manual 7th Edition Criteria for Colon Cancer: Do the Complex Modifications Improve Prognostic Assessment?Journal of the American College of Surgeons, 2013
- The functional consequences of alternative promoter use in mammalian genomesTrends in Genetics, 2008